Research location

Shanghai

China

Published trials1,582

Site observations2,457

Linked trials published1,582

Page1 / 32

Research activity in Shanghai

China

CureCurrent currently publishes aggregate city-level research activity for this location: 1,582 trials and 2,457 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Shanghai

1,582 linked trials · page 1 of 32

1-Week Versus 3-Week PBINCT07832279 · 2026-10-01 · 1 site observation

Hypofractionated vs. Conventionally Fractionated Postmastectomy Radiotherapy After Implant-Based ReconstructionNCT07835139 · 2026-10-01 · 1 site observation

A Clinical Study of HS-IT101 Injection in Patients With Advanced Non-Small Cell Lung CancerNCT07830342 · 2026-09-21 · 1 site observation

Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)NCT07653477 · 2026-09-07 · 1 site observation

Impact of GDMT in Uncontrolled Asthma Patients Receiving MHD Inhaled Corticosteroids + Long-acting β2 AgonistNCT07718724 · 2026-09-05 · 1 site observation

Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving SurgeryNCT07762924 · 2026-09-01 · 1 site observation

Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)NCT07778316 · 2026-08-28 · 1 site observation

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFNCT07761117 · 2026-08-24 · 4 site observations

A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes MellitusNCT07775404 · 2026-08-21 · 1 site observation

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes MellitusNCT07784725 · 2026-08-19 · 1 site observation

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive DisorderNCT07775300 · 2026-08-14 · 1 site observation

Cardiopulmonary Exercise Testing-based High-intensity Interval Training For Improving Heart Failure With Preserved Ejection FractionNCT07693049 · 2026-08-10 · 1 site observation

SKB264 in Combination With SKB118 for Non-Small Cell Lung CancerNCT07697586 · 2026-08-07 · 1 site observation

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)NCT07759245 · 2026-08-07 · 1 site observation

A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced TumoursNCT07533708 · 2026-07-30 · 1 site observation

A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLCNCT07586202 · 2026-07-28 · 1 site observation

Development of an Intraoperative Adaptive Biopsy System for Prostate Cancer: Integrating Imaging Navigation With Metabolic Feedback for Dynamic Decision-MakingNCT07856017 · 2026-07-21 · 4 site observations

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes MellitusNCT07662044 · 2026-07-06 · 1 site observation

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes MellitusNCT07662109 · 2026-07-06 · 2 site observations

A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 DiabetesNCT07670416 · 2026-07-03 · 4 site observations

Neoadjuvant Pyrotinib-to-pertuzumab in HER2+ eBCNCT07797218 · 2026-07-01 · 1 site observation

Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving SurgeryNCT07762885 · 2026-07-01 · 1 site observation

Directional PSA Versus STN DBS for TD-PDNCT07700862 · 2026-07-01 · 1 site observation

dACC-Targeted Temporal Interference for Negative and Cognitive Symptoms in SchizophreniaNCT07658898 · 2026-06-30 · 1 site observation

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMNCT07667803 · 2026-06-29 · 3 site observations

Real-World Outcomes of Resected EGFR-Mutated NSCLC Patients Treated With Adjuvant EGFR-TKI in ChinaNCT07593248 · 2026-06-22 · 1 site observation

Risk Factor Assessment for Acute Pulmonary Hypertension CrisisNCT07653958 · 2026-06-17 · 1 site observation

Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma DiagnosisNCT07516184 · 2026-06-10 · 4 site observations

A Phase II Clinical Study of the Efficacy and Safety of Culmerciclib Rechallenge in HR-positive, HER2-negative Breast Cancer Patients With Resistance to First-line Endocrine Therapy.NCT07666555 · 2026-06-06 · 1 site observation

Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without PembrolizumabNCT07486817 · 2026-06-04 · 1 site observation

A Study of MET Concordance and Gene Profiling in 1L NSCLC (Genomet)NCT07613424 · 2026-06-02 · 1 site observation

A Preliminary Clinical Study Protocol for Evaluating the Efficacy and Safety of Pulse Electric Field Ablation Systems in Treating Adult Type 2 Diabetes Mellitus With Suboptimal Drug ControlNCT07678866 · 2026-06-01 · 1 site observation

A Phase II Study of GC101 in NSCLCNCT07560111 · 2026-06-01 · 1 site observation

Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.NCT07279935 · 2026-05-26 · 3 site observations

A Study of TRC003 in the Treatment of Patients With Progressive PSMA-positive mCRPCNCT07567521 · 2026-05-22 · 1 site observation

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-PositiveNCT07413939 · 2026-05-21 · 1 site observation

CGM for Insulin-Treated T2DM During Post-Discharge TransitionNCT07414277 · 2026-05-11 · 4 site observations

Artificial Intelligence Model-Guided Neoadjuvant Anti-HER2 Targeted TherapyNCT07528716 · 2026-05-06 · 1 site observation

Opportunistic Breast Cancer Screening Using Non-Contrast Chest CTNCT07557654 · 2026-05-06 · 1 site observation

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)NCT07611110 · 2026-05-04 · 2 site observations

Neoadjuvant QL1706 in Patients With Hormone Receptor Positive, HER2-negative Breast CancerNCT07396324 · 2026-05-01 · 1 site observation

Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLCNCT07554846 · 2026-05-01 · 1 site observation

Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's DiseaseNCT07571161 · 2026-04-30 · 5 site observations

Ultra-Hypofractionated vs Moderate Hypofractionated Radiotherapy for Regional Lymph Nodes in High Risk Breast CancerNCT07527689 · 2026-04-22 · 1 site observation

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate CancerNCT07365995 · 2026-04-22 · 1 site observation

Effects of Gamified Rehabilitation on Cognitive and Psychosocial Outcomes in Inpatients With SchizophreniaNCT07557368 · 2026-04-19 · 1 site observation

The Effect of Game-Based Intervention on the Cognition of Schizophrenia PatientsNCT07557381 · 2026-04-19 · 1 site observation

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NECNCT07416695 · 2026-04-17 · 1 site observation

RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLCNCT07541521 · 2026-04-13 · 1 site observation

miRNA Panel for PCa DiagnosisNCT07755592 · 2026-04-13 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.